ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,827.04
-1.54%
US Tech 100
20,263.20
-1.69%
Dow Jones
41,938.45
-1.63%
Brent Oil
80.825
0.26%
Bitcoin
95,743.42
1.33%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Eterna Therapeutics Inc (ERNA) Quote

Eterna Therapeutics Inc

Eterna Therapeutics Inc (ERNA)

Is $ul-sh Bd A
0.30
-0.0233
(-7.21%)
At close: January 12 4:00PM
Delayed by 15 minutes
0.3036
0.0036
( 1.20% )
After Hours: 7:50PM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
0.3036
Bid
0.2513
Ask
0.37
Volume
301,458
0.2915 Day's Range 0.326
0.2212 52 Week Range 2.625
Market Cap
15.597M
Previous Close
0.3233
Open
0.3092
Last Trade
5
@
0.3036
Last Trade Time
19:40:51
Financial Volume
$ 90,663
VWAP
0.300749
Average Volume (3m)
930,717
Shares Outstanding
51,374,713
Dividend Yield
-
PE Ratio
-0.71
Earnings Per Share (EPS)
-0.42
Revenue
68k
Net Profit
-21.68M

About Eterna Therapeutics Inc

Eterna Therapeutics Inc is a biopharmaceutical company. The company develops transformational new medicines using advanced cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indicati... Eterna Therapeutics Inc is a biopharmaceutical company. The company develops transformational new medicines using advanced cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs. Show more

Sector
Pharmaceutical Preparations
Industry
Television Broadcast Station
Website
eternatx.com
Headquarters
Wilmington, Delaware, USA
Founded
2022
Eterna Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ERNA. The last closing price for Eterna Therapeutics was $0.32. Over the last year, Eterna Therapeutics shares have traded in a share price range of $ 0.2212 to $ 2.625.

Eterna Therapeutics currently has 51,374,713 shares outstanding. The market capitalization of Eterna Therapeutics is $16.61 million. Eterna Therapeutics has a price to earnings ratio (PE ratio) of -0.71.

Ask ADVFN Intelligence (AI)

ERNA Latest News

More News

Form 8-K - Current report

January 10 2025
Edgar (US Regulatory)

Eterna Therapeutics Announces Appointment of Dr. Elena Ratner to Board of Directors

CAMBRIDGE, Mass., Jan. 09, 2025 (GLOBE NEWSWIRE) -- Eterna Therapeutics (Nasdaq: ERNA), a leader in cell therapies for the treatment of advanced solid tumors, today announced the appointment of...

January 09 2025
GlobeNewswire Inc.

Eterna Therapeutics Launches Research to Evaluate its Lead Induced Mesenchymal Stem Cell Therapy Candidate’s (ERNA-101) Ability to Induce and Modulate Antitumor Immunity in Ovarian Cancer and Breast Cancer Models

CAMBRIDGE, Mass., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics (Nasdaq: ERNA) today announced it will investigate the ability of its lead iMSC-based cell therapy (ERNA-101) to induce...

December 03 2024
GlobeNewswire Inc.

Eterna Therapeutics Announces Up to $1 Million Stock Repurchase Program

CAMBRIDGE, Mass., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics, Inc. (Nasdaq: ERNA), a leader in cell therapies, today announced that its Board of Directors has authorized a stock...

November 25 2024
GlobeNewswire Inc.

Form 424B3 - Prospectus [Rule 424(b)(3)]

November 18 2024
Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]

November 18 2024
Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness

November 18 2024
Edgar (US Regulatory)

Eterna Therapeutics Regains Compliance with NASDAQ for Continued Listing

CAMBRIDGE, Mass., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”) announced today that it has regained compliance with Nasdaq for continued...

November 14 2024
GlobeNewswire Inc.

Form D - Notice of Exempt Offering of Securities

November 14 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.036471-10.72452517270.3400710.370.30014759200.33432754CS
40.00913.089983022070.29450.39250.22127170980.30546219CS
12-0.7964-72.41.11.250.22129307170.34478328CS
26-1.5764-83.85106382981.882.6250.22124240070.37608174CS
52-1.6264-84.26943005181.932.6250.22122186370.40540476CS
156-3.8964-92.77142857144.27.150.22121232011.11261999CS
260-3.8964-92.77142857144.27.150.22121232011.11261999CS

ERNA - Frequently Asked Questions (FAQ)

What is the current Eterna Therapeutics share price?
The current share price of Eterna Therapeutics is $ 0.3036
How many Eterna Therapeutics shares are in issue?
Eterna Therapeutics has 51,374,713 shares in issue
What is the market cap of Eterna Therapeutics?
The market capitalisation of Eterna Therapeutics is USD 16.61M
What is the 1 year trading range for Eterna Therapeutics share price?
Eterna Therapeutics has traded in the range of $ 0.2212 to $ 2.625 during the past year
What is the PE ratio of Eterna Therapeutics?
The price to earnings ratio of Eterna Therapeutics is -0.71
What is the cash to sales ratio of Eterna Therapeutics?
The cash to sales ratio of Eterna Therapeutics is 230.77
What is the reporting currency for Eterna Therapeutics?
Eterna Therapeutics reports financial results in USD
What is the latest annual turnover for Eterna Therapeutics?
The latest annual turnover of Eterna Therapeutics is USD 68k
What is the latest annual profit for Eterna Therapeutics?
The latest annual profit of Eterna Therapeutics is USD -21.68M
What is the registered address of Eterna Therapeutics?
The registered address for Eterna Therapeutics is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Eterna Therapeutics website address?
The website address for Eterna Therapeutics is eternatx.com
Which industry sector does Eterna Therapeutics operate in?
Eterna Therapeutics operates in the TELEVISION BROADCAST STATION sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TRAWTraws Pharma Inc
$ 12.28
(52.36%)
316.75k
SAGESage Therapeutics Inc
$ 8.11
(46.13%)
1.12M
EHGOEshallgo Inc
$ 4.00
(22.32%)
1.06k
BKYIBIO key International Inc
$ 1.74
(16.00%)
16.18k
GCTKGlucoTrack Inc
$ 0.1355
(15.81%)
19.39M
TOIIWOncology Institute Inc
$ 0.01
(-35.90%)
3k
GIFTGiftify Inc
$ 1.10
(-15.29%)
861
CJETChijet Motor Company Inc
$ 1.73
(-14.78%)
264.93k
DRCTDirect Digital Holdings Inc
$ 1.41
(-14.02%)
307.09k
VMARVision Marine Technologies Inc
$ 1.85
(-13.95%)
1.72M
GCTKGlucoTrack Inc
$ 0.1355
(15.81%)
19.39M
CDTConduit Pharmaceuticals Inc
$ 0.1218
(-1.22%)
11.52M
RGTIRigetti Computing Inc
$ 8.07
(-9.63%)
10.44M
SVMHSRIVARU Holding Ltd
$ 0.062
(0.32%)
5.14M
BHATBlue Hat Interactive Entertainment Technology
$ 0.0878
(-0.34%)
4.36M

ERNA Discussion

View Posts
glenn1919 glenn1919 1 week ago
ERNA..............................https://stockcharts.com/h-sc/ui?s=ERNA&p=W&b=5&g=0&id=p86431144783
👍️0
tw0122 tw0122 2 weeks ago
.33/34 at .27 average this round 
👍️0
glenn1919 glenn1919 2 weeks ago
erna.......................https://stockcharts.com/h-sc/ui?s=erna&p=W&b=5&g=0&id=p86431144783
👍️0
Fairgrounds Fairgrounds 2 weeks ago
.3256
👍️0
tw0122 tw0122 2 weeks ago
.30 +
20%
👍️0
tw0122 tw0122 2 weeks ago
.32 the .20s will pay off
👍️0
tw0122 tw0122 4 weeks ago
$26-.27s looking better at .28
👍️0
tw0122 tw0122 1 month ago
Back in at .28 and they halt it
👍️0
tw0122 tw0122 1 month ago
The power of loading heavy at .28 beat down pays off
👍️0
tw0122 tw0122 1 month ago
Add .28s how low can she go longer term play perhaps 
👍️0
tw0122 tw0122 1 month ago
Back in at .30-.31 beat down price 
👍️0
glenn1919 glenn1919 1 month ago
ERNA........................................https://stockcharts.com/h-sc/ui?s=ERNA&p=W&b=5&g=0&id=p86431144783
👍️0
tw0122 tw0122 1 month ago
70% profit out in .70s  paid off to load .40s
👍️0
tw0122 tw0122 1 month ago
Add.40-.42
👍 1 🚀 1
tw0122 tw0122 2 months ago
Back in .45 still have share buyback in place 
👍 1 💯 1
tw0122 tw0122 2 months ago
.63 once it floats through weak resistance at .69-.71 off to dollar land $1
👍 1 🚀 1
tw0122 tw0122 2 months ago
.60 ..Even better off to $1 where it was last week 
👍 1 🚀 1
tw0122 tw0122 2 months ago
.55 now looking better
👍 1 🚀 1
tw0122 tw0122 2 months ago
In on .4999s hopefully bottom in at .51
👍️0
glenn1919 glenn1919 2 months ago
ERNA.......................https://stockcharts.com/h-sc/ui?s=ERNA&p=W&b=5&g=0&id=p86431144783

.

....................thx.....lost in the shuffle again..................
👍️0
tw0122 tw0122 2 months ago
1 million share buyback on this 2 million floater going to skyrocket..😵🥴🚀🚀🚀🚀🚀🚀🚀🚀

Eterna Therapeutics Announces Up to $1 Million Stock Repurchase ProgramNovember 25 2024 - 8:30AM
👍️0
tw0122 tw0122 2 months ago
Right back to $1s with announcement...91- 1.28 next profit zone.. The effective date of the reverse stock split has not yet been determined and will be announced by the Company at least two business days prior to its implementation.
👍 1 🚀 1
tw0122 tw0122 2 months ago
Board is retarded you can't comment on DDC without getting permission to start board 
👍️0
Invest-in-America Invest-in-America 2 months ago
ERNA: Yep, been scrutinizing that puppy tonight. (And comment about DDC???)
👍 1 🔥 1
tw0122 tw0122 2 months ago
Cooling down $1.10 + 31%
👍️0
Invest-in-America Invest-in-America 2 months ago
ERNA: Up circa 46% in the Post-Market right now --- likely continued reaction to regaining NASDAQ compliance, YESTERDAY.
👍️0
glenn1919 glenn1919 4 months ago
ERNA.........................https://stockcharts.com/h-sc/ui?s=ERNA&p=W&b=5&g=0&id=p86431144783
👍️0

Your Recent History

NASDAQ
ERNA
Eterna Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads